|
|
|
|
|
by dosinga
153 days ago
|
|
One thing that seems missing from a lot of these comparisons is the base rate of success for dieting itself. Most people who “start a diet” never meaningfully lose weight in the first place, or lose a small amount and plateau quickly. The cohort of “dieters who regain weight” is already heavily filtered toward the minority who were unusually successful at dieting to begin with. That selection bias matters a lot when you then compare regain rates. GLP-1s change that denominator. A much larger fraction of people who start the intervention actually lose substantial weight. So even if regain after stopping is faster conditional on having lost weight, the overall success rate (people who lose and keep off a clinically meaningful amount) may still be higher than dieting alone. In other words: “people who regain weight after stopping GLP-1s” vs “people who regain weight after dieting” ignores the much larger group of dieters who never lost anything to regain. From a population perspective, that’s a pretty important omission. |
|
Reading the article and its referenced study, I thought the cohort was "all who were included in the non-placebo group of the RCT" and that the average was taken over all such subjects.
I've tried, can't find any evidence to the contrary. I am wrong and missing some key claim in the study? I would appreciate if you could support your claim.